Quantitative Mechanistic Modeling in Support of Pharmacological Therapeutics Development in Immuno-Oncology

immuno-oncology, mechanistic models, tumor vs. immune system, systems pharmacology, pharmacokinetics, pharmacodynamics, molecular and cellular biomarkers

There has been significant growth in the development of immuno-modulating pharmacological treatments for various cancers following the approval of the first immune checkpoint inhibitor. Challenges in immuno-oncology (IO) drug development are complex and span from the discovery phase to late-…

Apr 30^th • 12 mins read

The Talent Inflection Point in Pharma and Biotech: A Challenge to Companies — and a Call to Candidates

hiring, talent demand, job market

As pipelines advance and execution accelerates, pharma and biotech hiring may shift again in 2026, reshaping talent demand.

Feb 4^th • 7 mins read